Real-time enrollment status for this anaplastic large cell lymphoma, alk-negative clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:44 PM UTC
| NCT Number | NCT06724237 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Large Cell Lymphoma, ALK-Negative |
| Phase | PHASE3 |
| Target Enrollment | 294 participants |
| Active Locations | 164 sites in the US |
| Sponsor | Eastern Cooperative Oncology Group |
| Last Updated on CT.gov | September 14, 2026 (4 weeks ago) |
As of October 12, 2026: Clinical trial NCT06724237 is currently recruiting participants. This phase3 study for anaplastic large cell lymphoma, alk-negative is actively seeking new participants at 164 locations across the United States. The study is sponsored by Eastern Cooperative Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06724237 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 164 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06724237 was last updated 4 weeks ago (September 14, 2026). HelloStudys verifies this status automatically.